glp-1 compounding crackdown news october 2025 FDA Puts Pressure on Compounders, Telehealth Providers FDA steps up crackdown on

The numbers tell the story: 8-10% of Americans are currently using GLP-1 medications, with another 30-35% expressing interest

The Importance of Medical Oversight Working with a licensed pharmacist ensures that your therapy remains safe and properly monitored

These findings underscore that the inflammatory profiles observed in Fabry disease and amyloidosis exhibit greater intensity compared to the varied stages and severity seen in myocarditis

doi: 10.1007/978-3-319-71779-1_3 33

Scientifically, PT-141 is a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone (-MSH), specifically targeting the melanocortin-4 receptor (MC4R) to enhance sexual signaling without affecting blood pressure or heart rate like some other treatments.[4] At the most basic level, PT-141 activates brain centers that control sexual desire, increasing blood flow to genital tissues, improving sensitivity, and promoting natural lubricationall without relying on hormonal changes, making it suitable for women who can't or prefer not to use estrogen-based therapies.[4] Its role goes far beyond just sparking interest